🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 19 (from laksa054)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa019.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/\')), getAhrefsUnparsedNoserviceFromURL(\'https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/247wallst.com\/investing\/2025\/09\/03\/michael-burry-of-big-short-fame-loves-these-3-stocks\/","crawl_time":1775375682,"first_indexed_time":1756904452,"http_code":200,"src_unparsed":"com,247wallst!\/investing\/2025\/09\/03\/michael-burry-of-big-short-fame-loves-these-3-stocks\/ s443","src_root_hash":"288293324663574819","history_drop_reason":null,"meta_title":"Michael Burry of Big Short Fame Loves These 3 Stocks - 24\/7 Wall St.","meta_descriptions":[],"attrs_boilerpipe_text":"This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.\n© Photo by Astrid Stawiarz\/Getty Images\nI’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results.\nThough the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025. \nUndoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount.\nOnce again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry.\nLululemon\nLululemon\n(\nNASDAQ:LULU\n) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago.\nWith more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins.\nEnough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P\/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market.\nAre you ahead, or behind on retirement?\nSmartAsset's free tool\ncan match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute;\nlearn more here.\n(Sponsor)\nAt a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet.\nRegeneron Pharmaceuticals\nRegeneron Pharmaceuticals\n(\nNASDAQ:REGN\n) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise.\nAt 14.6 times trailing P\/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech. \nUnitedHealth Group\nA lot of smart money managers loaded up on\nUnitedHealth Group\n(\nNYSE:UNH\n) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around.\nThere are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P\/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P\/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why.\nIf You’ve Been Thinking About Retirement, Pay Attention\n(sponsor)\nRetirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:\nAnswer a few simple questions\nGet Matched with Vetted Advisors \nChoose Your  Fit \nWhy wait? Start building the retirement you’ve always dreamed of.\nGet started today!\n(sponsor)","attrs_markdown":"[Skip to content](https:\/\/247wallst.com\/investing\/2025\/09\/03\/michael-burry-of-big-short-fame-loves-these-3-stocks\/#content)\n\n[![24\/7 Wall Street Logo](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/logo.svg)](https:\/\/247wallst.com\/)\n\n- [Investing](https:\/\/247wallst.com\/investing\/)\n- [Personal Finance](https:\/\/247wallst.com\/personal-finance\/)\n- [Technology](https:\/\/247wallst.com\/technology-3\/)\n- [Economy and Geopolitics](https:\/\/247wallst.com\/investing\/2025\/09\/03\/michael-burry-of-big-short-fame-loves-these-3-stocks\/)\n  - [Economy](https:\/\/247wallst.com\/economy\/)\n  - [Politics](https:\/\/247wallst.com\/politics\/)\n  - [Crime](https:\/\/247wallst.com\/crime\/)\n  - [Infrastructure](https:\/\/247wallst.com\/infrastructure\/)\n  - [Military](https:\/\/247wallst.com\/military\/)\n  \n  ### Trending Articles\n  [![Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https:\/\/247wallst.com\/wp-content\/uploads\/2022\/03\/imageForEntry3-Lvv.jpg) 2 hours ago Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https:\/\/247wallst.com\/investing\/2026\/04\/05\/alibaba-has-a-new-agentic-ai-chip-too-but-investors-dont-seem-to-care\/)\n  \n  [![XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https:\/\/247wallst.com\/wp-content\/uploads\/2026\/04\/shutterstock-2664762491-huge-licensed-scaled-150x100.jpg) 9 hours ago XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https:\/\/247wallst.com\/investing\/2026\/04\/04\/xrp-price-breaches-key-support-xrp-crashed-50-the-last-time-it-broke-this-level\/)\n- [AI Portfolio](https:\/\/247wallst.com\/ai-portfolio\/ \"The 24\/7 AI Portfolio Hub\")\n\n[AI Investor Podcast](https:\/\/podcast.247wallst.com\/?utm_source=247wallst&utm_campaign=site_topnav)\n\n![Mobile Menu](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/mobile-menu-icon.svg)\n\n- [Investing](https:\/\/247wallst.com\/investing\/)\n- [Personal Finance](https:\/\/247wallst.com\/personal-finance\/)\n- [Technology](https:\/\/247wallst.com\/technology-3\/)\n- [Economy and Geopolitics](https:\/\/247wallst.com\/investing\/2025\/09\/03\/michael-burry-of-big-short-fame-loves-these-3-stocks\/)\n  - [Economy](https:\/\/247wallst.com\/economy\/)\n  - [Politics](https:\/\/247wallst.com\/politics\/)\n  - [Crime](https:\/\/247wallst.com\/crime\/)\n  - [Infrastructure](https:\/\/247wallst.com\/infrastructure\/)\n  - [Military](https:\/\/247wallst.com\/military\/)\n- [AI Portfolio](https:\/\/247wallst.com\/ai-portfolio\/ \"The 24\/7 AI Portfolio Hub\")\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-down.svg) S\\&P 500 6,568.00 -0.31%](https:\/\/247wallst.com\/indices\/sp-500\/)\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-down.svg) Dow Jones 46,434.70 -0.26%](https:\/\/247wallst.com\/indices\/dow-jones\/)\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-down.svg) Nasdaq 100 23,976.60 -0.36%](https:\/\/247wallst.com\/indices\/nasdaq-100\/)\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-down.svg) Russell 2000 2,516.69 -0.46%](https:\/\/247wallst.com\/indices\/russell-2000\/)\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-up.svg) FTSE 100 10,464.20 +0.29%](https:\/\/247wallst.com\/indices\/ftse-100\/)\n\n[![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-circle-up.svg) Nikkei 225 53,196.00 +0.16%](https:\/\/247wallst.com\/indices\/nikkei-225\/)\n\n![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-category-tag.svg)\n\n[Investing](https:\/\/247wallst.com\/investing\/)\n# Michael Burry of Big Short Fame Loves These 3 Stocks\n![Photo of Joey Frenette](https:\/\/secure.gravatar.com\/avatar\/532b61ea9241b6be2939a723837c48a8?s=120&d=mm&r=g)\n\nBy  [Joey Frenette](https:\/\/247wallst.com\/author\/joey-frenette\/)\n\nPublished\n\nSep 3, 8:54AM EDT\n\n### Key Points\n- Dr. Michael Burry has shed light on a number of intriguing value stocks in Q2.\n- LULU, REGN and UNH really do stand out as oversold names that are too cheap for their own good.\n- Are you ahead, or behind on retirement? [SmartAsset's free tool](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=b4521e20-1778-43ce-8785-eac54fd73ce3&pos=keypoints&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=keypoints&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=b4521e20-1778-43ce-8785-eac54fd73ce3&pos=keypoints&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=keypoints&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521)(Sponsor)\n\n[Follow 24\/7 Wall St. on Google](https:\/\/profile.google.com\/cp\/Cg0vZy8xMWR5bWZtX3Nk)\n\nThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.\n\n\n\n### How to Add Us to Google News\n![Add to Google News](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/social\/gnews-desktop-follow.png) ![Add to Google News](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/social\/gnews-follow.gif)\n\nSending You to Google News in 3\n\n![Michael Burry of Big Short Fame Loves These 3 Stocks](https:\/\/247wallst.com\/wp-content\/uploads\/2024\/12\/GettyImages-498541178-scaled.jpg)\n\n© Photo by Astrid Stawiarz\/Getty Images\n\nI’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results.\n\nThough the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025.\n\nUndoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount.\n\nOnce again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry.\n\n![Lululemon store](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/07\/imageForEntry18-YNQ.jpg)\n\nKevork Djansezian \/ Getty Images News via Getty Images\n## Lululemon\n**Lululemon** ([NASDAQ:LULU](https:\/\/247wallst.com\/companies\/lulu?tpid=1525521&tv=link&tc=in_content)) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago.\n\nWith more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins.\n\nEnough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P\/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market.\n\nAre you ahead, or behind on retirement? [SmartAsset's free tool](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)(Sponsor)\n\nAt a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet.\n\n![](https:\/\/247wallst.com\/wp-content\/uploads\/2022\/01\/imageForEntry64-VlG.jpg)\n\nMarianVejcik \/ iStock via Getty Images\n## Regeneron Pharmaceuticals\n**Regeneron Pharmaceuticals** ([NASDAQ:REGN](https:\/\/247wallst.com\/companies\/regen?tpid=1525521&tv=link&tc=in_content)) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise.\n\nAt 14.6 times trailing P\/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech.\n\n![](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/10\/imageForEntry11-5m2.jpg)\n\nWolterk \/ iStock Editorial via Getty Images\n## UnitedHealth Group\nA lot of smart money managers loaded up on **UnitedHealth Group** ([NYSE:UNH](https:\/\/247wallst.com\/companies\/unh?tpid=1525521&tv=link&tc=in_content)) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around.\n\nThere are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P\/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P\/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why.\n\n## If You’ve Been Thinking About Retirement, Pay Attention (sponsor)\nRetirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:\n\n1. [**Answer a few simple questions**](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)\n2. **Get Matched with Vetted Advisors**\n3. **Choose Your Fit**\n\nWhy wait? Start building the retirement you’ve always dreamed of. [**Get started today! (sponsor)**](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)\n\n![Photo of Joey Frenette](https:\/\/secure.gravatar.com\/avatar\/532b61ea9241b6be2939a723837c48a8?s=192&d=mm&r=g)\n\nAbout the Author  [Joey Frenette →](https:\/\/247wallst.com\/author\/joey-frenette\/)\n\nJoey is a 24\/7 Wall St. contributor and seasoned investment writer whose work can also be found in publications such as The Motley Fool and TipRanks. Holding a B.A.Sc in Computer Engineering from the University of British Columbia (UBC), Joey has leveraged his technical background to provide insightful stock analyses to readers.\n\nJoey's investment philosophy is heavily influenced by Warren Buffett's value investing principles. As a dedicated Buffett disciple, Joey is committed to unearthing value in the tech sector and beyond.\n\nMore Content\n\n[![Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https:\/\/247wallst.com\/wp-content\/uploads\/2022\/03\/imageForEntry3-Lvv.jpg) Joey Frenette • Apr 5, 2026 Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https:\/\/247wallst.com\/investing\/2026\/04\/05\/alibaba-has-a-new-agentic-ai-chip-too-but-investors-dont-seem-to-care\/)\n\n[![XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https:\/\/247wallst.com\/wp-content\/uploads\/2026\/04\/shutterstock-2664762491-huge-licensed-scaled-200x133.jpg) Sam Daodu • Apr 4, 2026 XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https:\/\/247wallst.com\/investing\/2026\/04\/04\/xrp-price-breaches-key-support-xrp-crashed-50-the-last-time-it-broke-this-level\/)\n\n[![XRP Price Prediction: We Asked ChatGPT What XRP Will Be Worth After the Iran War Ends](https:\/\/247wallst.com\/wp-content\/uploads\/2026\/04\/shutterstock-2278148907-huge-licensed-scaled-200x90.jpg) Sam Daodu • Apr 4, 2026 XRP Price Prediction: We Asked ChatGPT What XRP Will Be Worth After the Iran War Ends](https:\/\/247wallst.com\/investing\/2026\/04\/04\/xrp-price-prediction-we-asked-chatgpt-what-xrp-will-be-worth-after-the-iran-war-ends\/)\n\nCompanies Mentioned\n\n[![LULU logo](https:\/\/247wallst.com\/workers\/logos\/ticker\/LULU) LULU Lululemon -- --%](https:\/\/247wallst.com\/companies\/lulu\/)\n\n[![REGN logo](https:\/\/247wallst.com\/workers\/logos\/ticker\/REGN) REGN Regeneron -- --%](https:\/\/247wallst.com\/companies\/regn\/)\n\n[![UNH logo](https:\/\/247wallst.com\/workers\/logos\/ticker\/UNH) UNH UnitedHealth Group -- --%](https:\/\/247wallst.com\/companies\/unh\/)\n\n## Featured Reads\nOur top personal finance-related articles today. Your wallet will thank you later.\n\n[![She'll Inherit Large Sums and I’m Still Paying Half the Bills - Is This Arrangement Fair?](https:\/\/247wallst.com\/wp-content\/uploads\/2025\/02\/shutterstock-1492614863-huge-licensed-scaled-400x266.jpg)](https:\/\/247wallst.com\/personal-finance\/2026\/04\/04\/shell-inherit-large-sums-and-im-still-paying-half-the-bills-is-this-arrangement-fair\/)\n\n[Christy Bieber](https:\/\/247wallst.com\/author\/christy-bieber\/) \\|\n\n21 hours ago\n\n[She'll Inherit Large Sums and I’m Still Paying Half the Bills - Is This Arrangement Fair?](https:\/\/247wallst.com\/personal-finance\/2026\/04\/04\/shell-inherit-large-sums-and-im-still-paying-half-the-bills-is-this-arrangement-fair\/)\n\n[![The Hidden Retirement Costs Tax Planning Can Help You Avoid](https:\/\/247wallst.com\/wp-content\/uploads\/2025\/03\/shutterstock-347274356-huge-licensed-scaled-400x267.jpg)](https:\/\/247wallst.com\/personal-finance\/2026\/04\/02\/the-hidden-retirement-costs-tax-planning-can-help-you-avoid\/)\n\n[David Beren](https:\/\/247wallst.com\/author\/david-beren\/) \\|\n\nApr 2, 2026 at 6:00 AM EDT\n\n[The Hidden Retirement Costs Tax Planning Can Help You Avoid](https:\/\/247wallst.com\/personal-finance\/2026\/04\/02\/the-hidden-retirement-costs-tax-planning-can-help-you-avoid\/)\n\n## Continue Reading\n[![2 Stocks Michael Burry Just Bought](https:\/\/247wallst.com\/wp-content\/uploads\/2019\/05\/imageforentry16-srf.jpg) Joey Frenette \\| Nov 5, 2025 at 2:20 PM EST 2 Stocks Michael Burry Just Bought Dr. Michael Burry of “The Big Short” fame shocked many, enraged some, and intrigued everyone when he pulled the curtain…](https:\/\/247wallst.com\/investing\/2025\/11\/05\/2-stocks-michael-burry-just-bought\/)\n\n[![From Big Short to Big Long: Michael Burry Bets Big on Three Stocks](https:\/\/247wallst.com\/wp-content\/uploads\/2024\/12\/GettyImages-498541178-400x272.jpg) Rich Duprey \\| Aug 15, 2025 at 11:37 AM EDT From Big Short to Big Long: Michael Burry Bets Big on Three Stocks Michael Burry, the hedge fund maverick immortalized in The Big Short for his prescient bet against the mid-2000s housing bubble,…](https:\/\/247wallst.com\/investing\/2025\/08\/15\/from-big-short-to-big-long-michael-burry-bets-big-on-three-stocks\/)\n\n[![Michael Burry Just Boosted His Chinese Stock Holdings—Is it Time to Bet on China Comeback?](https:\/\/247wallst.com\/wp-content\/uploads\/2024\/03\/shutterstock-675058390-huge-licensed-scaled-400x273.jpg) Joey Frenette \\| Nov 18, 2024 at 10:37 AM EST Michael Burry Just Boosted His Chinese Stock Holdings—Is it Time to Bet on China Comeback? Dr. Michael Burry is a contrarian investor who’s not afraid to act in a big way if he sees value…](https:\/\/247wallst.com\/investing\/2024\/11\/18\/michael-burry-just-boosted-his-chinese-stock-holdings-is-it-time-to-bet-on-china-comeback\/)\n\n[![The Billionaire Investor Who Bet Against Nvidia and Palantir Is Buying Adobe](https:\/\/247wallst.com\/wp-content\/uploads\/2018\/09\/adobe-systems.jpg) Rich Duprey \\| Mar 4, 2026 at 11:30 AM EST The Billionaire Investor Who Bet Against Nvidia and Palantir Is Buying Adobe Billionaire investor Michael Burry earned his reputation as a legendary contrarian by betting against the U.S. housing market before the…](https:\/\/247wallst.com\/investing\/2026\/03\/04\/the-billionaire-investor-who-bet-against-nvidia-and-palantir-is-buying-adobe\/)\n\n[![Why Are Warren Buffett and Michael Burry Selling Stocks?](https:\/\/247wallst.com\/wp-content\/uploads\/2020\/09\/imageForEntry27-PVO.jpg) Joey Frenette \\| Sep 10, 2024 at 8:52 AM EDT Why Are Warren Buffett and Michael Burry Selling Stocks? Warren Buffett, the Oracle of Omaha, and Dr. Michael Burry, Christian Bale’s character in the film The Big Short, are…](https:\/\/247wallst.com\/investing\/2024\/09\/10\/why-are-warren-buffett-and-michael-burry-selling-stocks\/)\n\n[![2 Michael Burry Stocks to Buy on China’s Stimulus Plan](https:\/\/247wallst.com\/wp-content\/uploads\/2024\/03\/shutterstock-675058390-huge-licensed-scaled-400x273.jpg) Joey Frenette \\| Oct 8, 2024 at 8:00 AM EDT 2 Michael Burry Stocks to Buy on China’s Stimulus Plan Dr. Michael Burry, the brilliant investor who bet against the housing market before the 2008 meltdown, is a smart investor…](https:\/\/247wallst.com\/investing\/2024\/10\/08\/2-michael-burry-stocks-to-buy-on-chinas-stimulus-plan\/)\n\n[![3 Stocks Billionaire David Tepper Just Scooped Up](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/07\/imageForEntry20-aEz.jpg) Joey Frenette \\| Sep 8, 2025 at 11:14 AM EDT 3 Stocks Billionaire David Tepper Just Scooped Up Billionaire investment legend David Tepper was quite busy in the second quarter, as he added to his stake in a…](https:\/\/247wallst.com\/investing\/2025\/09\/08\/3-stocks-billionaire-david-tepper-just-scooped-up\/)\n\n[![3 of the Most Notable Big Money Bets](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/09\/imageForEntry5-msR.jpg) Joey Frenette \\| Jun 16, 2025 at 1:35 PM EDT 3 of the Most Notable Big Money Bets Hedge funds made some pretty interesting bets in the first quarter of this year, and a lot of them, I…](https:\/\/247wallst.com\/investing\/2025\/06\/16\/3-of-the-most-notable-big-money-bets\/)\n\n[![This Cheap Stock Had Jim Cramer’s Blessing—Time to Buy?](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/07\/imageForEntry18-YNQ.jpg) Joey Frenette \\| Jun 6, 2025 at 9:38 AM EDT This Cheap Stock Had Jim Cramer’s Blessing—Time to Buy? After you’ve put in the homework on a given stock, getting the viewpoints from the smart folks on Wall Street…](https:\/\/247wallst.com\/investing\/2025\/06\/06\/this-cheap-stock-had-jim-cramers-blessing-time-to-buy\/)\n\n## ![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-trend-up.svg) Top Gaining Stocks\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/SBAC)\n\n[SBA Communications](https:\/\/247wallst.com\/companies\/sbac\/)\n\n[SBAC](https:\/\/247wallst.com\/companies\/sbac\/)  • Vol: 6,563,665\n\n\\+\\$32.48\n\n\\+18.93%\n\n\\$204.04\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/INTC)\n\n[Intel](https:\/\/247wallst.com\/companies\/intc\/)\n\n[INTC](https:\/\/247wallst.com\/companies\/intc\/)  • Vol: 116,894,024\n\n\\+\\$2.35\n\n\\+4.89%\n\n\\$50.38\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/CCI)\n\n[Crown Castle](https:\/\/247wallst.com\/companies\/cci\/)\n\n[CCI](https:\/\/247wallst.com\/companies\/cci\/)  • Vol: 6,078,125\n\n\\+\\$3.95\n\n\\+4.89%\n\n\\$84.78\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/DASH)\n\n[DoorDash](https:\/\/247wallst.com\/companies\/dash\/)\n\n[DASH](https:\/\/247wallst.com\/companies\/dash\/)  • Vol: 5,051,322\n\n\\+\\$5.95\n\n\\+3.95%\n\n\\$156.45\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/GLW)\n\n[Corning](https:\/\/247wallst.com\/companies\/glw\/)\n\n[GLW](https:\/\/247wallst.com\/companies\/glw\/)  • Vol: 11,572,082\n\n\\+\\$5.54\n\n\\+3.89%\n\n\\$147.92\n\n## ![](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/icon-trend-down.svg) Top Losing Stocks\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/ENPH)\n\n[Enphase Energy](https:\/\/247wallst.com\/companies\/enph\/)\n\n[ENPH](https:\/\/247wallst.com\/companies\/enph\/)  • Vol: 6,441,768\n\n\\-\\$3.36\n\n8\\.78%\n\n\\$34.92\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/TSLA)\n\n[Tesla](https:\/\/247wallst.com\/companies\/tsla\/)\n\n[TSLA](https:\/\/247wallst.com\/companies\/tsla\/)  • Vol: 82,993,122\n\n\\-\\$20.67\n\n5\\.42%\n\n\\$360.59\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/GE)\n\n[General Electric](https:\/\/247wallst.com\/companies\/ge\/)\n\n[GE](https:\/\/247wallst.com\/companies\/ge\/)  • Vol: 5,322,694\n\n\\-\\$11.52\n\n3\\.94%\n\n\\$281.16\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/LKQ)\n\n[LKQ](https:\/\/247wallst.com\/companies\/lkq\/)\n\n[LKQ](https:\/\/247wallst.com\/companies\/lkq\/)  • Vol: 4,320,256\n\n\\-\\$1.12\n\n3\\.82%\n\n\\$28.19\n\n![](https:\/\/247wallst.com\/workers\/logos\/ticker\/SWK)\n\n[Stanley Black & Decker](https:\/\/247wallst.com\/companies\/swk\/)\n\n[SWK](https:\/\/247wallst.com\/companies\/swk\/)  • Vol: 2,144,540\n\n\\-\\$2.53\n\n3\\.55%\n\n\\$68.64\n\n[![24\/7 Wall St. logo](https:\/\/247wallst.com\/wp-content\/themes\/247wallst-theme-2025\/assets\/images\/logo.svg)](https:\/\/247wallst.com\/)\n\n- [Home](https:\/\/247wallst.com\/)\n- [About Us](https:\/\/247wallst.com\/about-us\/)\n- [Contact Us](https:\/\/247wallst.com\/contact\/)\n- [Financial Tools](https:\/\/247wallst.com\/financial-tools\/)\n- [Disclaimer and Terms of Use](https:\/\/247wallst.com\/disclaimer-and-terms-of-use\/)\n- [Privacy Policy](https:\/\/247wallst.com\/privacy-policy\/)\n- [CCPA Privacy Policy](https:\/\/247wallst.com\/ccpa-privacy-policy\/)\n- [Advertise](https:\/\/247wallst.com\/advertise\/)\n\n© 2026 24\/7 Wall St.\n\n[Flip this article on Flipboard](https:\/\/share.flipboard.com\/bookmarklet\/popout?v=2&title=Michael%20Burry%20of%20Big%20Short%20Fame%20Loves%20These%203%20Stocks&url=https%3A%2F%2F247wallst.com%2Finvesting%2F2025%2F09%2F03%2Fmichael-burry-of-big-short-fame-loves-these-3-stocks%2F%3Futm_source%3Dflipboard%26utm_medium%3Dsocial%26utm_campaign%3Dflipboard-share-bar)","attrs_readable_markdown":"This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.\n\n![Michael Burry of Big Short Fame Loves These 3 Stocks](https:\/\/247wallst.com\/wp-content\/uploads\/2024\/12\/GettyImages-498541178-scaled.jpg)\n\n© Photo by Astrid Stawiarz\/Getty Images\n\nI’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results.\n\nThough the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025.\n\nUndoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount.\n\nOnce again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry.\n\n![Lululemon store](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/07\/imageForEntry18-YNQ.jpg)\n\n## Lululemon\n**Lululemon** ([NASDAQ:LULU](https:\/\/247wallst.com\/companies\/lulu?tpid=1525521&tv=link&tc=in_content)) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago.\n\nWith more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins.\n\nEnough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P\/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market.\n\nAre you ahead, or behind on retirement? [SmartAsset's free tool](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)(Sponsor)\n\nAt a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet.\n\n![](https:\/\/247wallst.com\/wp-content\/uploads\/2022\/01\/imageForEntry64-VlG.jpg)\n\n## Regeneron Pharmaceuticals\n**Regeneron Pharmaceuticals** ([NASDAQ:REGN](https:\/\/247wallst.com\/companies\/regen?tpid=1525521&tv=link&tc=in_content)) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise.\n\nAt 14.6 times trailing P\/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech.\n\n![](https:\/\/247wallst.com\/wp-content\/uploads\/2021\/10\/imageForEntry11-5m2.jpg)\n\n## UnitedHealth Group\nA lot of smart money managers loaded up on **UnitedHealth Group** ([NYSE:UNH](https:\/\/247wallst.com\/companies\/unh?tpid=1525521&tv=link&tc=in_content)) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around.\n\nThere are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P\/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P\/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why.\n\n## If You’ve Been Thinking About Retirement, Pay Attention (sponsor)\nRetirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:\n\n1. [**Answer a few simple questions**](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)\n2. **Get Matched with Vetted Advisors**\n3. **Choose Your Fit**\n\nWhy wait? Start building the retirement you’ve always dreamed of. [**Get started today! (sponsor)**](https:\/\/247wallst.com\/go\/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

15 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.5 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/
Last Crawled	2026-04-05 07:54:42 (15 days ago)
First Indexed	2025-09-03 13:00:52 (7 months ago)
HTTP Status Code	200
Meta Title	Michael Burry of Big Short Fame Loves These 3 Stocks - 24/7 Wall St.
Meta Description	null
Meta Canonical	null
Boilerpipe Text	This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. © Photo by Astrid Stawiarz/Getty Images I’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results. Though the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025. Undoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount. Once again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry. Lululemon Lululemon ( NASDAQ:LULU ) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago. With more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins. Enough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market. Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here. (Sponsor) At a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet. Regeneron Pharmaceuticals Regeneron Pharmaceuticals ( NASDAQ:REGN ) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise. At 14.6 times trailing P/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech. UnitedHealth Group A lot of smart money managers loaded up on UnitedHealth Group ( NYSE:UNH ) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around. There are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why. If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how: Answer a few simple questions Get Matched with Vetted Advisors Choose Your Fit Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
Markdown	[Skip to content](https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/#content) [![24/7 Wall Street Logo](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/logo.svg)](https://247wallst.com/) - [Investing](https://247wallst.com/investing/) - [Personal Finance](https://247wallst.com/personal-finance/) - [Technology](https://247wallst.com/technology-3/) - [Economy and Geopolitics](https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/) - [Economy](https://247wallst.com/economy/) - [Politics](https://247wallst.com/politics/) - [Crime](https://247wallst.com/crime/) - [Infrastructure](https://247wallst.com/infrastructure/) - [Military](https://247wallst.com/military/) ### Trending Articles [![Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https://247wallst.com/wp-content/uploads/2022/03/imageForEntry3-Lvv.jpg) 2 hours ago Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https://247wallst.com/investing/2026/04/05/alibaba-has-a-new-agentic-ai-chip-too-but-investors-dont-seem-to-care/) [![XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https://247wallst.com/wp-content/uploads/2026/04/shutterstock-2664762491-huge-licensed-scaled-150x100.jpg) 9 hours ago XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https://247wallst.com/investing/2026/04/04/xrp-price-breaches-key-support-xrp-crashed-50-the-last-time-it-broke-this-level/) - [AI Portfolio](https://247wallst.com/ai-portfolio/ "The 24/7 AI Portfolio Hub") [AI Investor Podcast](https://podcast.247wallst.com/?utm_source=247wallst&utm_campaign=site_topnav) ![Mobile Menu](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/mobile-menu-icon.svg) - [Investing](https://247wallst.com/investing/) - [Personal Finance](https://247wallst.com/personal-finance/) - [Technology](https://247wallst.com/technology-3/) - [Economy and Geopolitics](https://247wallst.com/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/) - [Economy](https://247wallst.com/economy/) - [Politics](https://247wallst.com/politics/) - [Crime](https://247wallst.com/crime/) - [Infrastructure](https://247wallst.com/infrastructure/) - [Military](https://247wallst.com/military/) - [AI Portfolio](https://247wallst.com/ai-portfolio/ "The 24/7 AI Portfolio Hub") [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-down.svg) S\&P 500 6,568.00 -0.31%](https://247wallst.com/indices/sp-500/) [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-down.svg) Dow Jones 46,434.70 -0.26%](https://247wallst.com/indices/dow-jones/) [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-down.svg) Nasdaq 100 23,976.60 -0.36%](https://247wallst.com/indices/nasdaq-100/) [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-down.svg) Russell 2000 2,516.69 -0.46%](https://247wallst.com/indices/russell-2000/) [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-up.svg) FTSE 100 10,464.20 +0.29%](https://247wallst.com/indices/ftse-100/) [![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-circle-up.svg) Nikkei 225 53,196.00 +0.16%](https://247wallst.com/indices/nikkei-225/) ![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-category-tag.svg) [Investing](https://247wallst.com/investing/) # Michael Burry of Big Short Fame Loves These 3 Stocks ![Photo of Joey Frenette](https://secure.gravatar.com/avatar/532b61ea9241b6be2939a723837c48a8?s=120&d=mm&r=g) By [Joey Frenette](https://247wallst.com/author/joey-frenette/) Published Sep 3, 8:54AM EDT ### Key Points - Dr. Michael Burry has shed light on a number of intriguing value stocks in Q2. - LULU, REGN and UNH really do stand out as oversold names that are too cheap for their own good. - Are you ahead, or behind on retirement? [SmartAsset's free tool](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=b4521e20-1778-43ce-8785-eac54fd73ce3&pos=keypoints&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=keypoints&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=b4521e20-1778-43ce-8785-eac54fd73ce3&pos=keypoints&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=keypoints&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521)(Sponsor) [Follow 24/7 Wall St. on Google](https://profile.google.com/cp/Cg0vZy8xMWR5bWZtX3Nk) This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ### How to Add Us to Google News ![Add to Google News](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/social/gnews-desktop-follow.png) ![Add to Google News](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/social/gnews-follow.gif) Sending You to Google News in 3 ![Michael Burry of Big Short Fame Loves These 3 Stocks](https://247wallst.com/wp-content/uploads/2024/12/GettyImages-498541178-scaled.jpg) © Photo by Astrid Stawiarz/Getty Images I’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results. Though the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025. Undoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount. Once again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry. ![Lululemon store](https://247wallst.com/wp-content/uploads/2021/07/imageForEntry18-YNQ.jpg) Kevork Djansezian / Getty Images News via Getty Images ## Lululemon Lululemon ([NASDAQ:LULU](https://247wallst.com/companies/lulu?tpid=1525521&tv=link&tc=in_content)) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago. With more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins. Enough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market. Are you ahead, or behind on retirement? [SmartAsset's free tool](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)(Sponsor) At a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet. ![](https://247wallst.com/wp-content/uploads/2022/01/imageForEntry64-VlG.jpg) MarianVejcik / iStock via Getty Images ## Regeneron Pharmaceuticals Regeneron Pharmaceuticals ([NASDAQ:REGN](https://247wallst.com/companies/regen?tpid=1525521&tv=link&tc=in_content)) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise. At 14.6 times trailing P/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech. ![](https://247wallst.com/wp-content/uploads/2021/10/imageForEntry11-5m2.jpg) Wolterk / iStock Editorial via Getty Images ## UnitedHealth Group A lot of smart money managers loaded up on UnitedHealth Group ([NYSE:UNH](https://247wallst.com/companies/unh?tpid=1525521&tv=link&tc=in_content)) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around. There are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why. ## If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how: 1. [Answer a few simple questions](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) 2. Get Matched with Vetted Advisors 3. Choose Your Fit Why wait? Start building the retirement you’ve always dreamed of. [Get started today! (sponsor)](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) ![Photo of Joey Frenette](https://secure.gravatar.com/avatar/532b61ea9241b6be2939a723837c48a8?s=192&d=mm&r=g) About the Author [Joey Frenette →](https://247wallst.com/author/joey-frenette/) Joey is a 24/7 Wall St. contributor and seasoned investment writer whose work can also be found in publications such as The Motley Fool and TipRanks. Holding a B.A.Sc in Computer Engineering from the University of British Columbia (UBC), Joey has leveraged his technical background to provide insightful stock analyses to readers. Joey's investment philosophy is heavily influenced by Warren Buffett's value investing principles. As a dedicated Buffett disciple, Joey is committed to unearthing value in the tech sector and beyond. More Content [![Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https://247wallst.com/wp-content/uploads/2022/03/imageForEntry3-Lvv.jpg) Joey Frenette • Apr 5, 2026 Alibaba Has a New Agentic AI Chip, Too—But Investors Don’t Seem to Care](https://247wallst.com/investing/2026/04/05/alibaba-has-a-new-agentic-ai-chip-too-but-investors-dont-seem-to-care/) [![XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https://247wallst.com/wp-content/uploads/2026/04/shutterstock-2664762491-huge-licensed-scaled-200x133.jpg) Sam Daodu • Apr 4, 2026 XRP Price Breaches Key Support: XRP Crashed 50% the Last Time It Broke This Level](https://247wallst.com/investing/2026/04/04/xrp-price-breaches-key-support-xrp-crashed-50-the-last-time-it-broke-this-level/) [![XRP Price Prediction: We Asked ChatGPT What XRP Will Be Worth After the Iran War Ends](https://247wallst.com/wp-content/uploads/2026/04/shutterstock-2278148907-huge-licensed-scaled-200x90.jpg) Sam Daodu • Apr 4, 2026 XRP Price Prediction: We Asked ChatGPT What XRP Will Be Worth After the Iran War Ends](https://247wallst.com/investing/2026/04/04/xrp-price-prediction-we-asked-chatgpt-what-xrp-will-be-worth-after-the-iran-war-ends/) Companies Mentioned [![LULU logo](https://247wallst.com/workers/logos/ticker/LULU) LULU Lululemon -- --%](https://247wallst.com/companies/lulu/) [![REGN logo](https://247wallst.com/workers/logos/ticker/REGN) REGN Regeneron -- --%](https://247wallst.com/companies/regn/) [![UNH logo](https://247wallst.com/workers/logos/ticker/UNH) UNH UnitedHealth Group -- --%](https://247wallst.com/companies/unh/) ## Featured Reads Our top personal finance-related articles today. Your wallet will thank you later. [![She'll Inherit Large Sums and I’m Still Paying Half the Bills - Is This Arrangement Fair?](https://247wallst.com/wp-content/uploads/2025/02/shutterstock-1492614863-huge-licensed-scaled-400x266.jpg)](https://247wallst.com/personal-finance/2026/04/04/shell-inherit-large-sums-and-im-still-paying-half-the-bills-is-this-arrangement-fair/) [Christy Bieber](https://247wallst.com/author/christy-bieber/) \\| 21 hours ago [She'll Inherit Large Sums and I’m Still Paying Half the Bills - Is This Arrangement Fair?](https://247wallst.com/personal-finance/2026/04/04/shell-inherit-large-sums-and-im-still-paying-half-the-bills-is-this-arrangement-fair/) [![The Hidden Retirement Costs Tax Planning Can Help You Avoid](https://247wallst.com/wp-content/uploads/2025/03/shutterstock-347274356-huge-licensed-scaled-400x267.jpg)](https://247wallst.com/personal-finance/2026/04/02/the-hidden-retirement-costs-tax-planning-can-help-you-avoid/) [David Beren](https://247wallst.com/author/david-beren/) \\| Apr 2, 2026 at 6:00 AM EDT [The Hidden Retirement Costs Tax Planning Can Help You Avoid](https://247wallst.com/personal-finance/2026/04/02/the-hidden-retirement-costs-tax-planning-can-help-you-avoid/) ## Continue Reading [![2 Stocks Michael Burry Just Bought](https://247wallst.com/wp-content/uploads/2019/05/imageforentry16-srf.jpg) Joey Frenette \\| Nov 5, 2025 at 2:20 PM EST 2 Stocks Michael Burry Just Bought Dr. Michael Burry of “The Big Short” fame shocked many, enraged some, and intrigued everyone when he pulled the curtain…](https://247wallst.com/investing/2025/11/05/2-stocks-michael-burry-just-bought/) [![From Big Short to Big Long: Michael Burry Bets Big on Three Stocks](https://247wallst.com/wp-content/uploads/2024/12/GettyImages-498541178-400x272.jpg) Rich Duprey \\| Aug 15, 2025 at 11:37 AM EDT From Big Short to Big Long: Michael Burry Bets Big on Three Stocks Michael Burry, the hedge fund maverick immortalized in The Big Short for his prescient bet against the mid-2000s housing bubble,…](https://247wallst.com/investing/2025/08/15/from-big-short-to-big-long-michael-burry-bets-big-on-three-stocks/) [![Michael Burry Just Boosted His Chinese Stock Holdings—Is it Time to Bet on China Comeback?](https://247wallst.com/wp-content/uploads/2024/03/shutterstock-675058390-huge-licensed-scaled-400x273.jpg) Joey Frenette \\| Nov 18, 2024 at 10:37 AM EST Michael Burry Just Boosted His Chinese Stock Holdings—Is it Time to Bet on China Comeback? Dr. Michael Burry is a contrarian investor who’s not afraid to act in a big way if he sees value…](https://247wallst.com/investing/2024/11/18/michael-burry-just-boosted-his-chinese-stock-holdings-is-it-time-to-bet-on-china-comeback/) [![The Billionaire Investor Who Bet Against Nvidia and Palantir Is Buying Adobe](https://247wallst.com/wp-content/uploads/2018/09/adobe-systems.jpg) Rich Duprey \\| Mar 4, 2026 at 11:30 AM EST The Billionaire Investor Who Bet Against Nvidia and Palantir Is Buying Adobe Billionaire investor Michael Burry earned his reputation as a legendary contrarian by betting against the U.S. housing market before the…](https://247wallst.com/investing/2026/03/04/the-billionaire-investor-who-bet-against-nvidia-and-palantir-is-buying-adobe/) [![Why Are Warren Buffett and Michael Burry Selling Stocks?](https://247wallst.com/wp-content/uploads/2020/09/imageForEntry27-PVO.jpg) Joey Frenette \\| Sep 10, 2024 at 8:52 AM EDT Why Are Warren Buffett and Michael Burry Selling Stocks? Warren Buffett, the Oracle of Omaha, and Dr. Michael Burry, Christian Bale’s character in the film The Big Short, are…](https://247wallst.com/investing/2024/09/10/why-are-warren-buffett-and-michael-burry-selling-stocks/) [![2 Michael Burry Stocks to Buy on China’s Stimulus Plan](https://247wallst.com/wp-content/uploads/2024/03/shutterstock-675058390-huge-licensed-scaled-400x273.jpg) Joey Frenette \\| Oct 8, 2024 at 8:00 AM EDT 2 Michael Burry Stocks to Buy on China’s Stimulus Plan Dr. Michael Burry, the brilliant investor who bet against the housing market before the 2008 meltdown, is a smart investor…](https://247wallst.com/investing/2024/10/08/2-michael-burry-stocks-to-buy-on-chinas-stimulus-plan/) [![3 Stocks Billionaire David Tepper Just Scooped Up](https://247wallst.com/wp-content/uploads/2021/07/imageForEntry20-aEz.jpg) Joey Frenette \\| Sep 8, 2025 at 11:14 AM EDT 3 Stocks Billionaire David Tepper Just Scooped Up Billionaire investment legend David Tepper was quite busy in the second quarter, as he added to his stake in a…](https://247wallst.com/investing/2025/09/08/3-stocks-billionaire-david-tepper-just-scooped-up/) [![3 of the Most Notable Big Money Bets](https://247wallst.com/wp-content/uploads/2021/09/imageForEntry5-msR.jpg) Joey Frenette \\| Jun 16, 2025 at 1:35 PM EDT 3 of the Most Notable Big Money Bets Hedge funds made some pretty interesting bets in the first quarter of this year, and a lot of them, I…](https://247wallst.com/investing/2025/06/16/3-of-the-most-notable-big-money-bets/) [![This Cheap Stock Had Jim Cramer’s Blessing—Time to Buy?](https://247wallst.com/wp-content/uploads/2021/07/imageForEntry18-YNQ.jpg) Joey Frenette \\| Jun 6, 2025 at 9:38 AM EDT This Cheap Stock Had Jim Cramer’s Blessing—Time to Buy? After you’ve put in the homework on a given stock, getting the viewpoints from the smart folks on Wall Street…](https://247wallst.com/investing/2025/06/06/this-cheap-stock-had-jim-cramers-blessing-time-to-buy/) ## ![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-trend-up.svg) Top Gaining Stocks ![](https://247wallst.com/workers/logos/ticker/SBAC) [SBA Communications](https://247wallst.com/companies/sbac/) [SBAC](https://247wallst.com/companies/sbac/) • Vol: 6,563,665 \+\$32.48 \+18.93% \$204.04 ![](https://247wallst.com/workers/logos/ticker/INTC) [Intel](https://247wallst.com/companies/intc/) [INTC](https://247wallst.com/companies/intc/) • Vol: 116,894,024 \+\$2.35 \+4.89% \$50.38 ![](https://247wallst.com/workers/logos/ticker/CCI) [Crown Castle](https://247wallst.com/companies/cci/) [CCI](https://247wallst.com/companies/cci/) • Vol: 6,078,125 \+\$3.95 \+4.89% \$84.78 ![](https://247wallst.com/workers/logos/ticker/DASH) [DoorDash](https://247wallst.com/companies/dash/) [DASH](https://247wallst.com/companies/dash/) • Vol: 5,051,322 \+\$5.95 \+3.95% \$156.45 ![](https://247wallst.com/workers/logos/ticker/GLW) [Corning](https://247wallst.com/companies/glw/) [GLW](https://247wallst.com/companies/glw/) • Vol: 11,572,082 \+\$5.54 \+3.89% \$147.92 ## ![](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/icon-trend-down.svg) Top Losing Stocks ![](https://247wallst.com/workers/logos/ticker/ENPH) [Enphase Energy](https://247wallst.com/companies/enph/) [ENPH](https://247wallst.com/companies/enph/) • Vol: 6,441,768 \-\$3.36 8\.78% \$34.92 ![](https://247wallst.com/workers/logos/ticker/TSLA) [Tesla](https://247wallst.com/companies/tsla/) [TSLA](https://247wallst.com/companies/tsla/) • Vol: 82,993,122 \-\$20.67 5\.42% \$360.59 ![](https://247wallst.com/workers/logos/ticker/GE) [General Electric](https://247wallst.com/companies/ge/) [GE](https://247wallst.com/companies/ge/) • Vol: 5,322,694 \-\$11.52 3\.94% \$281.16 ![](https://247wallst.com/workers/logos/ticker/LKQ) [LKQ](https://247wallst.com/companies/lkq/) [LKQ](https://247wallst.com/companies/lkq/) • Vol: 4,320,256 \-\$1.12 3\.82% \$28.19 ![](https://247wallst.com/workers/logos/ticker/SWK) [Stanley Black & Decker](https://247wallst.com/companies/swk/) [SWK](https://247wallst.com/companies/swk/) • Vol: 2,144,540 \-\$2.53 3\.55% \$68.64 [![24/7 Wall St. logo](https://247wallst.com/wp-content/themes/247wallst-theme-2025/assets/images/logo.svg)](https://247wallst.com/) - [Home](https://247wallst.com/) - [About Us](https://247wallst.com/about-us/) - [Contact Us](https://247wallst.com/contact/) - [Financial Tools](https://247wallst.com/financial-tools/) - [Disclaimer and Terms of Use](https://247wallst.com/disclaimer-and-terms-of-use/) - [Privacy Policy](https://247wallst.com/privacy-policy/) - [CCPA Privacy Policy](https://247wallst.com/ccpa-privacy-policy/) - [Advertise](https://247wallst.com/advertise/) © 2026 24/7 Wall St. [Flip this article on Flipboard](https://share.flipboard.com/bookmarklet/popout?v=2&title=Michael%20Burry%20of%20Big%20Short%20Fame%20Loves%20These%203%20Stocks&url=https%3A%2F%2F247wallst.com%2Finvesting%2F2025%2F09%2F03%2Fmichael-burry-of-big-short-fame-loves-these-3-stocks%2F%3Futm_source%3Dflipboard%26utm_medium%3Dsocial%26utm_campaign%3Dflipboard-share-bar)
Readable Markdown	This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ![Michael Burry of Big Short Fame Loves These 3 Stocks](https://247wallst.com/wp-content/uploads/2024/12/GettyImages-498541178-scaled.jpg) © Photo by Astrid Stawiarz/Getty Images I’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S. housing market, but because he’s a very interesting individual who stands out as the ultimate contrarian. Even when there’s investor resistance, he has conviction. And whenever you match doctor-level smarts (yes, he’s a real medical doctor) with a contrarian mindset and the ability to stay confident in one’s abilities, you could have the formula for market-clobbering results. Though the Great Financial Crisis (GFC) and the Big Short were a long time ago, I wouldn’t discount Burry’s bets. He’s still making moves and getting pretty stellar results, especially relative to his hedge fund rivals. In this piece, we’ll cover three names that Burry picked up for Scion Asset Management in the second quarter of 2025. Undoubtedly, Burry was an aggressive seller in the first quarter, paring everything but one name. Now, it looks like he’s back on track to go long on a number of names. Though it’s unknown whether Burry bought into that Liberation Day sell-off that happened in the second quarter, I certainly wouldn’t be surprised if he treated the correction as an opportunity to pick up merchandise at a discount. Once again, Burry’s decision to sell in the first quarter was an incredibly bold call that was absolutely the right one to make. And the timing couldn’t have been better. Mark it down as another genius move by the great Dr. Burry. ![Lululemon store](https://247wallst.com/wp-content/uploads/2021/07/imageForEntry18-YNQ.jpg) ## Lululemon Lululemon ([NASDAQ:LULU](https://247wallst.com/companies/lulu?tpid=1525521&tv=link&tc=in_content)) was Scion’s biggest buy for the second quarter, and it’s perhaps one of the most unfashionable of late. Indeed, the Canadian brand was one of the go-to brands in the athleisure scene a few years ago. With more rivals bringing their mat to the yoga room, though, I question the power of the brand and its ability to command a premium. With sales in a rough spot and additional markdowns likely on the way, Lululemon could feel more of a pinch in the margins. Enough with the negative, though. Lululemon goes for 13.7 times trailing price-to-earnings (P/E), a multiple that would have been ridiculous just a year and a half ago, when Lululemon was on top of the yoga world. Although I understand the deep-value proposition behind the name, LULU still stands out as a bit risky, especially if its rival, Alo, is able to outstretch it for a larger share of the fiercely competitive athletic apparel market. Are you ahead, or behind on retirement? [SmartAsset's free tool](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; [learn more here.](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=c63fdcc8-4b70-48d1-b726-b48913b9a012&pos=mid_content&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)(Sponsor) At a more than 60% discount, Lululemon seems tempting. But the big Burry bet isn’t one I’d look for to follow the man into quite yet. ![](https://247wallst.com/wp-content/uploads/2022/01/imageForEntry64-VlG.jpg) ## Regeneron Pharmaceuticals Regeneron Pharmaceuticals ([NASDAQ:REGN](https://247wallst.com/companies/regen?tpid=1525521&tv=link&tc=in_content)) is another interesting dip-buy that most other retail investors may be sleeping on. The stock cratered close to 60% before recovering partial ground. Now down 52% from the peak, Scion has essentially picked up shares at close to half price. Indeed, Regeneron has a robust portfolio and a pipeline with plenty of promise. At 14.6 times trailing P/E, you’re getting a pretty solid biopharma name for far less than a market multiple. With a strong quarter behind it and a hopeful bottom already in the charts, perhaps Regeneron stands out as one of the best deep-value bets for investors looking to bet on biotech. ![](https://247wallst.com/wp-content/uploads/2021/10/imageForEntry11-5m2.jpg) ## UnitedHealth Group A lot of smart money managers loaded up on UnitedHealth Group ([NYSE:UNH](https://247wallst.com/companies/unh?tpid=1525521&tv=link&tc=in_content)) in the second quarter. The stock crashed hard, and while a turnaround could take time, I do think the stock could be ready to ascend again now that managers are already hard at work on measures to turn things around. There are a lot of industry headwinds right now, but there are company-specific matters the firm can improve upon as the name climbs out of a historic rut. The stock goes for 13.4 times trailing P/E to go with a nearly 3% yield. Fans of the name a year ago should be looking to double down after the walloping the managed health provider took earlier this year. UNH stock isn’t just another bruised stock with a P/E ratio in the low-teens. It’s a hedge fund favorite, and it’s not hard to see why. ## If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how: 1. [Answer a few simple questions](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content) 2. Get Matched with Vetted Advisors 3. Choose Your Fit Why wait? Start building the retirement you’ve always dreamed of. [Get started today! (sponsor)](https://247wallst.com/go/smartasset?i=7d10f1ee-2ba1-4306-a0be-18b4c81ffaa3&p=e4e7e03f-b8cf-4538-928b-9e3bad6b9b0c&pos=end_of_article&c=f2085e18-eba1-4e74-9bde-a8f9fc6616ea&l=af843ef5-2aa8-4217-81a3-b81305acda7b&site=247wallst&utm_medium=in_content&utm_campaign=site&utm_source=%28direct%29&utm_content=desktop%7C%7C1525521&tpid=1525521&tv=link&tc=in_content)
Shard	19 (laksa)
Root Hash	288293324663574819
Unparsed URL	com,247wallst!/investing/2025/09/03/michael-burry-of-big-short-fame-loves-these-3-stocks/ s443